Skip to main content
. 2023 Aug 29;14:1238171. doi: 10.3389/fimmu.2023.1238171

Table 3.

Summary of patents filed over the last five years for drugs targeting ion channels.

PATENT ID TITLE LINK
US- 11008306- B2 Quinazolines as potassium ion channel inhibitors  https://patents.google.com/patent/US11008306B2/en
US-2022041552-A1 Charged ion channel blockers and methods for use  https://patents.google.com/patent/US20220041552A1/en
US-2019038573-A1 Ion channel activators and methods of use  https://patents.google.com/patent/US20190038573A1/en
US-2020101069-A1 CRAC channel inhibitors for the treatment of stroke and traumatic brain injury  https://patents.google.com/patent/US20200101069A1/en
US-2022193096-A1 Inhibitors of ncca-atp channels for therapy  https://patents.google.com/patent/US20220193096A1/en
JP-2021098713-A Permanently charged sodium and calcium channel blockers as anti-inflammatory agents  https://patents.google.com/patent/JP2021098713A/en
US-2020108056-A1 Liposomal Mitigation of Drug-Induced Inhibition of the Cardiac IKR Channel  https://patents.google.com/patent/US20200108056A1/en
US-10774050-B2 Pyrimidines as sodium channel blockers  https://patents.google.com/patent/US10774050B2/en
US-10350430-B2 System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1) https://patents.google.com/patent/US10350430B2/en
JP-2019142914-A Trpa1 inhibitors for treating pain https://patents.google.com/patent/JP2019142914A/en
US-11377438-B2 2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors https://patents.google.com/patent/US11377438B2/en
US-10898496-B2 Targeting NCCa-ATP channel for organ protection following ischemic episode  https://patents.google.com/patent/US10898496B2/en
US-2019111137-A1 Methods for antagonists of a non-selective cation channel in neural cells  https://patents.google.com/patent/US20190111137A1/en
US-2022227732-A1 Pyridine carboxamide compounds for inhibiting Nav1.8 https://patents.google.com/patent/US20220227732A1/en
JP-6630004-B2 Macrocycles as Factor XIA inhibitors with aromatic P2 'groups https://patents.google.com/patent/JP6630004B2/en
US-10668051-B2 Modulators of calcium release-activated calcium channel  https://patents.google.com/patent/US10668051B2/en
US-11357841-B2 Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof  https://patents.google.com/patent/US11357841B2/en
US-10701938-B2 Composition for inhibition of insect host sensing  https://patents.google.com/patent/US10701938B2/en
US-10653673-B2 Substituted imidazoles as N-type calcium channel blockers  https://patents.google.com/patent/US10653673B2/en
EP-3625214-B1 Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels  https://patents.google.com/patent/EP3625214B1/en
US-11192863-B2 Antiviral compounds and methods  https://patents.google.com/patent/US11192863B2/en
US-10472359-B2 Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl- 2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-d
e]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotoninreuptake transporter activity
US-10472359-B2 https://patents.google.com/patent/US10472359B2/en
JP-7072154-B2 Fertilizer pesticide product  https://patents.google.com/patent/JP7072154B2/en
US-10548886-B2 Methods of treatment using a JAK inhibitor compound  https://patents.google.com/patent/US10548886B2/en
US-2018172671-A1 Methods for treating neural cell swelling  https://patents.google.com/patent/US20180172671A1/en
ES-2882186-T3 JAK inhibitors containing a 4-membered heterocyclic amide https://patents.google.com/patent/ES2882186T3/en
US-2020163902-A1 Therapeutic agents targeting the NCCA-ATP channel and methods of use thereof  https://patents.google.com/patent/US20200163902A1/en
AU-2018200632-B2 Cystathionine-y-lyase (CSE) inhibitors  https://patents.google.com/patent/AU2018200632B2/en
US-11439639-B2 Pyrazine-containing compound  https://patents.google.com/patent/US11439639B2/en